Parents of woman who died of seizure after ChaGPT misguidance sue OpenAI
By Eric Berger · Nov 1, 2026, 4:02 PM CST
Bowen Wan was on anti-seizure medication, and chatbot provided her with a tapering schedule to reduce dosage A woman’s death from an epileptic seizure after she received dangerous advice from a chatbot has prompted her parents to sue OpenAI earlier this week. The legal action is the latest lawsuit that in which plaintiffs allege that a bot provided counsel to a user that ultimately led to their de
Excerpt shown under fair-use limits. Full text remains with the original publisher.
People in this coverage
Explore their history and attributable record. Being mentioned does not imply endorsement.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisSensationalismThe headline frames the story as a dramatic failure of the chatbot, using emotionally charged language (“misguidance”) to attract attention.
Attribution of BlameThe article attributes direct responsibility to the chatbot without presenting corroborating evidence, shaping reader perception of AI culpability.
Lack of Source DiversityThe story relies on a single, unnamed source (the lawsuit filing) and offers no statements from OpenAI, medical experts, or court documents.
Context
AI analysisMissing context
The article does not provide medical context about the risks of tapering anti‑seizure medication, any statements from OpenAI, details of the legal complaint, or independent verification of the chatbot interaction.
Important context
Tapering anti‑seizure medication can be medically risky and typically requires physician supervision; liability for AI‑generated health advice is legally complex and often depends on disclaimer language and user agreements.
Opinion vs. reporting
AI analysisThe piece blends reporting of the lawsuit with unverified causal claims, leaning toward an interpretive narrative rather than strictly factual reporting.